Search research articles
Contact Us
Filters
Showing results (51-60 of 81) with videos related to
Page
of 9
Sort By:
Reproductive Sciences (Thousand Oaks, Calif.)
|
February 17, 2017
Effects of an Antagonistic Analog of Growth Hormone-Releasing Hormone on Endometriosis in a Mouse Model and In Vitro
Frank Köster, Li Jin, Yuanming Shen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 21, 2013
Hypothalamo-pituitary and immune-dependent adrenal regulation during systemic inflammation
Waldemar Kanczkowski, Vasileia-Ismini Alexaki, Nguyen Tran, et al.
Hormones & Cancer
|
March 11, 2015
Expression of Receptors for Pituitary-Type Growth Hormone-Releasing Hormone (pGHRH-R) in Human Papillary Thyroid Cancer Cells: Effects of GHRH Antagonists on Matrix Metalloproteinase-2
Paola Catanuto, Jun Tashiro, Ferenc G Rick, et al.
Cell Cycle (Georgetown, Tex.)
|
July 4, 2012
Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers
Ferenc G Rick, Stefan Buchholz, Andrew V Schally, et al.
Oncotarget
|
August 6, 2016
Agonistic analogs of growth hormone releasing hormone (GHRH) promote wound healing by stimulating the proliferation and survival of human dermal fibroblasts through ERK and AKT pathways
Tengjiao Cui, Joaquin J Jimenez, Norman L Block, et al.
Endocrinology
|
August 20, 2014
In vivo fluorescence imaging and urinary monoamines as surrogate biomarkers of disease progression in a mouse model of pheochromocytoma
Martin Ullrich, Ralf Bergmann, Mirko Peitzsch, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 18, 2015
Beneficial effects of growth hormone-releasing hormone agonists on rat INS-1 cells and on streptozotocin-induced NOD/SCID mice
Xianyang Zhang, Tengjiao Cui, Jinlin He, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
February 13, 2016
Profound Actions of an Agonist of Growth Hormone-Releasing Hormone on Angiogenic Therapy by Mesenchymal Stem Cells
Qunchao Ma, Xiangyang Xia, Quanwei Tao, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 10, 2010
Agonist of growth hormone-releasing hormone as a potential effector for survival and proliferation of pancreatic islets
Barbara Ludwig, Christian G Ziegler, Andrew V Schally, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 29, 2017
Protective effects of agonists of growth hormone-releasing hormone (GHRH) in early experimental diabetic retinopathy
Menaka C Thounaojam, Folami L Powell, Sagar Patel, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 81) with videos related to
Sort By:
Page
of 9
Reproductive Sciences (Thousand Oaks, Calif.)
|
February 17, 2017
Effects of an Antagonistic Analog of Growth Hormone-Releasing Hormone on Endometriosis in a Mouse Model and In Vitro
Frank Köster, Li Jin, Yuanming Shen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 21, 2013
Hypothalamo-pituitary and immune-dependent adrenal regulation during systemic inflammation
Waldemar Kanczkowski, Vasileia-Ismini Alexaki, Nguyen Tran, et al.
Hormones & Cancer
|
March 11, 2015
Expression of Receptors for Pituitary-Type Growth Hormone-Releasing Hormone (pGHRH-R) in Human Papillary Thyroid Cancer Cells: Effects of GHRH Antagonists on Matrix Metalloproteinase-2
Paola Catanuto, Jun Tashiro, Ferenc G Rick, et al.
Cell Cycle (Georgetown, Tex.)
|
July 4, 2012
Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers
Ferenc G Rick, Stefan Buchholz, Andrew V Schally, et al.
Oncotarget
|
August 6, 2016
Agonistic analogs of growth hormone releasing hormone (GHRH) promote wound healing by stimulating the proliferation and survival of human dermal fibroblasts through ERK and AKT pathways
Tengjiao Cui, Joaquin J Jimenez, Norman L Block, et al.
Endocrinology
|
August 20, 2014
In vivo fluorescence imaging and urinary monoamines as surrogate biomarkers of disease progression in a mouse model of pheochromocytoma
Martin Ullrich, Ralf Bergmann, Mirko Peitzsch, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 18, 2015
Beneficial effects of growth hormone-releasing hormone agonists on rat INS-1 cells and on streptozotocin-induced NOD/SCID mice
Xianyang Zhang, Tengjiao Cui, Jinlin He, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
February 13, 2016
Profound Actions of an Agonist of Growth Hormone-Releasing Hormone on Angiogenic Therapy by Mesenchymal Stem Cells
Qunchao Ma, Xiangyang Xia, Quanwei Tao, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 10, 2010
Agonist of growth hormone-releasing hormone as a potential effector for survival and proliferation of pancreatic islets
Barbara Ludwig, Christian G Ziegler, Andrew V Schally, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 29, 2017
Protective effects of agonists of growth hormone-releasing hormone (GHRH) in early experimental diabetic retinopathy
Menaka C Thounaojam, Folami L Powell, Sagar Patel, et al.
Page
of 9